Inventiv Health Inc.

"Blane Walter was named CEO of inVentiv Health in May 2008, with responsibility for providing the strategic vision for the company, overseeing the four major operating divisions, and developing integrated solutions to meet client needs. Mr. Walter's previous positions at the company included serving as President of inVentiv Health and as President and CEO of the inVentiv Communications division. Mr. Walter also served as Chairman and CEO of inChord Communications, Inc. prior to its acquisition by inVentiv Health in October 2005. Mr. Walter joined inChord (then known as Gerbig, Snell/Weisheimer & Associates) as an Account Manager in 1994. In 1996, he became a partner and later purchased the company in 2000. Under his direction, inChord became the largest privately-held healthcare communication company in the world, working with 16 of the world's top 20 healthcare companies and serving clients around the world through a global network with offices in 13 countries. Prior to joining inChord, Mr. Walter worked as a Financial Analyst in New York City for Smith Barney in mergers and acquisitions. He holds a B.S. in Marketing and Finance from Boston College. "

"Mr. Broshy is Executive Chairman of the Board of inVentiv Health, Inc. Mr. Broshy joined inVentiv Health as Chief Executive Officer and Director in June 1999 and took the company public in the fall of 1999. He became Chairman of the Board in June 2006 and transitioned to the role of Executive Chairman in May 2008. Mr. Broshy has over 21 years' management and consulting experience within the healthcare industry and is a widely recognized industry expert and frequent speaker on strategic issues in the pharmaceutical and healthcare industries. Prior to joining inVentiv he served as the Partner responsible for the healthcare practice of The Boston Consulting Group (BCG) across the Americas. During his fourteen-year tenure at BCG from 1984 to 1998, Mr. Broshy consulted widely with senior executives from a number of the major global pharmaceutical manufacturers, managed care organizations, and academic medical centers, and advised on a range of strategic, organizational and operational issues. Mr. Broshy has also served as President and Chief Executive Officer of Coelacanth Corporation, a privately-held biotechnology company. Mr. Broshy currently also serves as a Director of Neurogen Corporation (Nasdaq: NRGN), a biotechnology company, and on the Simon Wiesenthal Center’s NY Executive Board. Mr. Broshy is a graduate of Harvard University (M.B.A.), Stanford University (M.S.), and Massachusetts Institute of Technology (B.S.) "

"Michael Hlinak has more than 20 years of financial and operations management experience in both publicly and privately owned organizations, including staffing, telecommunications, real estate development, and management, retail, and medical. As President and CEO of inVentiv Clinical Solutions, he leads the clinical development outsourced services business (inVentiv Clinical Solutions) as well as the clinical staffing groups (MedFocus and Smith Hanley Consulting Group). Mr. Hlinak took the reins of inVentiv Clinical Solutions after inVentiv Health's acquisition of Smith Hanley, an industry leading permanent executive placement and contract staffing firm. At Smith Hanley, he held the position of CFO, overseeing all financial aspects of the business and responsible for pursuing corporate development opportunities. Before Smith Hanley, Mr. Hlinak held senior financial positions at Work International Corporation, Equal Net and Cardinal Interests. Mr. Hlinak received a B.S. in Business Administration from Lamar University in Beaumont, Texas, and completed MBA coursework at the University of Houston. He is also a Certified Public Accountant in the state of Texas. "

"Terrell Herring has more than 20 years of experience in the pharmaceutical sales industry and is recognized for setting new performance standards for pharmaceutical outsourced services. In his current role as President, he oversees the four major divisions of the company – inVentiv Clinical, inVentiv Commercial, inVentiv Communications and inVentiv Patient Outcomes. Mr. Herring joined the company in November 1999 and has provided great leadership to the organization in various roles, including: National Business Director, Vice President and General Manager, U. S. Sales, President and COO, inVentiv Pharma Services, President and COO, inVentiv Commercial, and President and CEO, inVentiv Commercial. He was appointed to the Board of Directors of inVentiv Health in 2006 and was named COO of the corporation and CEO of the newly formed Patient Outcomes Group in early 2007. Prior to joining inVentiv, Mr. Herring was the Senior National Sales Director at Noven Pharmaceuticals and held various sales management, training and development, marketing, and operations positions at both Ciba-Geigy and Solvay Pharmaceuticals. Mr. Herring graduated magna cum laude from the Citadel, Military College of South Carolina where he earned a B.S. in Biology. Mr. Herring also attended Fairleigh Dickinson and Pacific Western University where he earned his M.B.A. In addition, Mr. Herring has received graduate certificates in Business and International Marketing from Mercer University School of Engineering and Duke University/London Business School. In March 2007, Mr. Herring published his first book, ""Marching Orders For Leadership Success"" and was recognized by PharmaVoice as one of the top 100 most inspirational and influential leaders in the life sciences industry. Mr. Herring has also been selected as the first Honoree for the Somerset and Hunterdon Big Brothers Big Sisters fund raising gala for the leadership and support that he has provided to the organization over the past decade. "

"As President and COO of inVentiv Communications, Mr. O'Donnell is responsible for strategic direction and oversight of inVentiv Communications and the 13 fully integrated companies within the division. He also oversees client relationships, new business activities and the division's operational backbone that includes the accounting/finance, human resources, marketing communications and technology departments. Prior to joining inVentiv Communications (then known as inChord) in 2001, Mr. O'Donnell was Chief Financial Officer for Bank One's Retail Customer and Channel Group (now JPMorgan Chase). In this role, he led a team of finance and accounting professionals to provide decision support, financial reporting and analysis, financial control and strategic and capital planning for a business unit management team. During Mr. O'Donnell's 17 years with Bank One, he held a number of other positions, including CFO of the Business Banking Group, where he was responsible for the financial management of the small business unit. He was also corporate finance liaison, where he acted as the liaison between the Retail line of business CFO and CEO and the Banc One Corporation CFO and COO. Mr. O'Donnell holds B.S. in Finance and Accounting from Miami University and an M.B.A. from the University of Dayton. He also completed the Executive Development Program at Darden School of Business, University of Virginia. "

As CMO for GSW Worldwide, Brian Heffernan is responsible for providing global and strategic marketing leadership with a focus on consumer and DTC efforts. He also leads the agency's health and well-being practice, helping marketers capitalize upon consumers' growing interest and involvement in health and well-being. Mr. Heffernan brings over 20 years of national and international consumer advertising experience. He has worked on many high-profile assignments for global marketers such as Nestle, Blockbuster, Kraft, Nabisco and Miller. Mr. Heffernan worked at J. Walter Thompson's (JWT) New York office. In 1997 he helped JWT make its initial transition from consumer agency to work in healthcare and DTC. He then went on to become president of JWT's Chicago office before joining GSW Worldwide.

"Bruce Rooke, CCO for GSW Worldwide, provides strategic leadership for the creative team. His responsibilities include establishing and implementing standards for creative work and ensuring that strategic, creative and branding processes are used consistently across the agency. Prior to GSW, Mr. Rooke worked as Executive Creative Director at J. Walter Thompson (JWT) in Detroit for 16 years where he was responsible for developing the Ford ""No Boundaries"" campaign featuring Bill Ford. In addition, he also served as Executive Vice President for JWT Worldwide and sat on the Worldwide Creative Council for JWT and WPP Group. Prior to joining JWT in 1989 as an Associate Creative Director, Mr. Rooke worked at W.B. Doner, eventually serving as creative group head. His accounts there included Canadian Tire, Vlasic Pickles, and Shasta. Mr. Rooke received a B.A. in English from the University of Michigan, Ann Arbor. "

"David Bassin is the CFO for inVentiv Health, Inc. He has been a leader in the organization for nearly 10 years in a variety of financial and strategic roles. Most recently, Mr. Bassin was CFO and COO for inVentiv Commercial, responsible for providing financial, strategic and operational management for all of the inVentiv Commercial divisions. He oversaw accounting/finance, information technology, fleet and the strategic development for the operations. In addition, Mr. Bassin led the financial due diligence and integration for newly acquired subsidiaries within the division and the insurance/risk management for the organization. After a career as an Auditor with Arthur Andersen, Mr. Bassin entered the pharmaceutical sales and marketing industry in 1998 as the Business and Financial Strategies Group Manager for Snyder Communications, a former parent company to inVentiv Health. He was responsible for post-acquisition integrations of subsidiaries that provided sales force, clinical research assistance and other marketing services to pharmaceutical companies in Europe. After assisting with investor relations and securing financing for the spin-off of inVentiv Health from Snyder Communications, Mr. Bassin led the financial planning and analysis group in the preparation of company-wide budgets, forecast and statistics for quarterly reports. He also acted as the Financial Director, performing financial modeling of partnerships for pharmaceutical and biotech products in late-stage development prior to his present role. Mr. Bassin earned a B.S. in Economics and Business from Lafayette College and is a Certified Public Accountant. "

Guy Mastrion has over 25 years of strategic and creative expertise across a wide range of advertising communications. From local to national and international advertising campaigns, from post cards to television, radio, internet, his unique combination of talents and creativity continue to be a driving force for Palio and their clients. Everyday at Palio he oversees the conception and execution of their work alongside his team of senior creative directors. Prior to joining Palio he was EVP managing director/creative director of Lowe McAdams NY where he specialized in the development and execution of all consumer television and direct marketing efforts. He has held executive level positions in some of the worlds' largest advertising agencies, including Bates, Saatchi and Saatchi and McCann Erickson. Mr. Mastrion received his Bachelor of Fine Arts degree from the Parsons School of Design.

"With more than 19 years of experience in the pharmaceutical sales industry, Peter Marchesini joined inVentiv Health in November 2002 as Executive Director, Specialty Sales Group. Mr. Marchesini worked with a team of National Business Directors responsible for 16 clients. For over two years, he has taken on the role of Chief Learning Officer of inVentiv Health, overseeing inVentiv's Client Training & Development, Professional Development Group, and Corporate Training & Development. Prior to inVentiv, Mr. Marchesini was the National Sales Director and Regional Medical Manager with Noven Pharmaceuticals, where he led a team that established and trained Noven's first sales force. Mr. Marchesini earned a B.S from San Diego State University. He has also served on the Board of Directors of the Certified Medical Representative Institute and was part of a team of training professionals associated with the American Red Cross Training Advisory Board. Mr. Marchesini has participated in panels and workshops for the Society of Pharmaceutical and Biotech Trainers (SPBT), Pharmaceutical Executive Sales and Marketing Summit, and CBI's Pharmaceutical Training Summit. "

"Tristen Herrstrom serves as Chief Resource Officer for inVentiv Health. She is responsible for all Human Resource functions, including recruitment services and benefits management within inVentiv Health, facilitating synergy in programs, policies, and practices across all divisions. Ms. Herrstrom's human resource career has focused in the healthcare, hospitality and outsourcing industries for the past 11 years, coming to inVentiv Health in 1998, where she served as Human Resource Management with Hallmark Health. During her tenure with inVentiv, Ms. Herrstrom has contributed to the significant reduction in employee turnover through the establishment of retention programs, including a management development program, an enhanced employee referral program and employee recognition programs. Ms. Herrstrom has also improved the employee benefits package with the addition of new products, while managing costs incurred by both the company and the participants. Ms. Herrstrom has a B.S. from The College of New Jersey and earned her M.S. Degree in Human Resource Counseling from Northeastern University. She is a member of the Society for Human Resource Management and the Healthcare Businesswoman's Association "

Tom Sottile is the Senior Vice President, Ventiv Sales and Marketing Teams, located in Somerset, New Jersey. Mr. Sottile leads Ventiv's sales and marketing teams focused on achieving and exceeding client goals and expectations. Prior to the sales and marketing responsibility, Mr. Sottile served as Vice President of Operations, which included The Ventiv Professional Development Group Total Data Solutions and PROMOTECH, along with Sample Accountability, Compliance and Fleet & Travel Administration. Mr. Sottile has more than 17 years of pharmaceutical sales and marketing experience. Before joining inVentiv he served as Sales Director for Curry, Martin Schiavelli, Inc. (CMS), a Medical Communication division of Torre Lazur and as an account director at Boron LePore. Mr. Sottile began his Pharmaceutical Sales and Marketing career at Solvay Pharmaceuticals, Inc. While at Solvay, he held a variety of responsibilities, including field sales representative, hospital specialist, sales trainer, sales manager, managed care account executive and product manager for the gastroenterology franchise. In addition to gastroenterology, Mr. Sottile has therapeutic experience in women's healthcare, CNS, respiratory and pain management. Mr. Sottile is a graduate of LaSalle University in Philadelphia, Pennsylvania, where he earned a Bachelor of Arts degree in Business Management and Personnel Labor Relations.

As Senior Vice President and Managing Director of Ventiv Recruitment Services, Mr. Vogel leads the Ventiv Recruitment Team of experts in the development of customized staffing solutions that deliver "on profile and on time" professionals committed to overachieving our customers expectations. Mr. Vogel has 26 years of pharmaceuticals sales, marketing and sales operations experience. Before joining inVentiv he served as Vice President of Sales and Sales Operations at NPS Pharmaceuticals. Mr. Vogel began his Pharmaceutical career as a sales representative at Searle Pharmaceuticals. Before joining NPS, Mr. Vogel was at Sanofi-Aventis where he held a variety of responsibilities including VP of Metabolism Sales, VP Respiratory Sales and VP Business Performance Improvement. Mr. Vogel earned his B.S. degree at Ball State University and MBA at Lake Forest School of Management and holds a Black Belt in Lean Six Sigma methodologies.

Mr. Charnetski has over 15 years of pharmaceutical marketing and market research experience across a vast array of therapeutic areas. He is responsible for the development and support of primary and syndicated market research initiatives within the Market Research group. During his tenure at HPR, Mr. Charnetski has spearheaded the launch of HPR's Metropolitan Area Promotional Audit and Rapid Recall services, in addition to overseeing HPR's Key Opinion Leader/Sphere of Influence Mapping capabilities.

Jeff Thomas is the Vice President and Managing Director of Ventiv Access Services, a division of inVentiv Commercial located in Somerset, New Jersey. Mr. Thomas leads the development and implementation of commercial and government product access strategies and tactics, including managed markets and trade channels. Mr. Thomas brings over 28 years of pharmaceutical experience with senior management responsibilities in sales, marketing, and managed markets. Prior to joining inVentiv, Mr. Thomas held the position of President, Ranbaxy Laboratories, a division of Ranbaxy Pharmaceuticals Inc., where he had full P&L responsibilities for building the branded products group in North America, including initial start-up, hiring of all personnel, and the launch of four products in the first full year of operation. Mr. Thomas earned a Bachelor of Science degree in Economics from West Liberty State College, West Virginia.

"As Senior Vice President, Managing Director of The Therapeutics Institute (TTI), Joy Morrell is responsible for the strategic vision and oversight of TTI, a company that provides dedicated teams of medical science liaisons and clinical educators to create and expand market opportunities and achieve business objectives for pharmaceutical and biotech clients. As a leader with strong clinical skills combined with vast business acumen, Ms. Morrell successfully has launched 28 educational programs. She has extensive experience with the compliance and OIG requirements that are needed to guide these programs. She also has an extensive background in nursing, including leadership and teaching experience in critical care, cardiovascular, public health and emergency medicine. Ms. Morrell previously worked in public health nursing, where she created the first integrated public health service system for women and children in the state of Vermont. The system later became a model for other states. Ms. Morrell also held various leadership positions for such companies as Roche, Fujisawa, Aprex and Innovex. During this time, she enjoyed a successful and progressive sales career, built the first medical science liaison and clinical teams for Innovex, and pioneered a patient compliance program for Aprex. Ms. Morrell's unique blend of clinical and pharmaceutical experience led to the creation of her own business called Loomis Samson, where she provided clinical support and patient education for the healthcare and pharmaceutical industry on a contract basis. Loomis Samson was integrated into The Therapeutics Institute in 2004 to enhance the breadth of offered services. "

Julia Kelly is Vice President, Account Management and Marketing under the inVentiv Commercial Division located in Somerset, New Jersey. In her role, Ms. Kelly leads both the Account Management process for the Commercial business and the marketing effort for all the inVentiv Health companies and divisions. Ms. Kelly brings more than 18 years of progressive healthcare sales and marketing experience to inVentiv Health, including a 15-year career with Mead Johnson Nutritionals, a division of Bristol-Myers Squibb. Ms. Kelly's tenure with Mead Johnson included various progressive leadership roles in both the sales and marketing organizations. Her expertise is built on the promotion of over 55 products, including adult and pediatric medical nutritionals, pharmaceuticals, laboratory tests, medical devices, medical services and other OTC products, to a variety of audiences within the healthcare industry. Since joining inVentiv in 2003, Ms. Kelly is credited with the marketing and PR campaign that repositioned inVentiv Health as provider of a variety of integrated commercialization solutions to the pharmaceutical industry. Prior to her career in sales and marketing, Ms. Kelly was a healthcare professional in the field of dietetics, having earned a B.S. in Nutrition from Penn State University. Ms. Kelly remains an active member of the American Dietetic Association and is on the Board of Directors for the metro chapter of the Healthcare Business Women's Association.

Robert Melillo is the Vice President & Managing Director of Sample Management for Ventiv Pharma Services, a division of inVentiv Commercial located in Somerset, New Jersey. Mr. Melillo is responsible for the coordination and growth of the whole-system sample management offering, including sampling activities within The Franklin Group, Health Products Research, Pharmaceutical Resource Solutions and PROMOTECH. Mr. Melillo has over 10 years of industry experience representing a variety of pharmaceutical companies, warehousing distributors, contract sales organizations, software developers, etc., with regard to the regulatory impact on the business. Mr. Melillo was responsible for licensing inVentiv with the first CSO narcotic drug sampling program. In addition to this program, Mr. Melillo led several sampling programs for companies such as Bristol-Myers Squibb, Johnson & Johnson, Searle, and Pharmacia. Mr. Melillo holds a Juris Doctor from Albany Law School and a Bachelor of Science degree from Trinity College in Connecticut.

Stephen Cottrell brings almost 20 years of industry experience to inVentiv Clinical Solutions. In his role as Executive Vice President of Operations and Business Development, he is responsible for leading marketing and business development efforts for all clinical divisions to drive revenue growth for the company. Prior to rejoining the inVentiv family, Mr. Cottrell served as Executive Vice President and then President of AAI Development Services, where he led a midsized CRO providing services from late-stage discovery through Phase IV to North America, Western Europe, and Japan. He also served as Executive Vice President of EduNeering Holdings, Inc., where he led the sales and marketing efforts for a small venture-funded company providing online training services focused on clinical development within the pharmaceutical and health insurance industries. Mr. Cottrell holds a B.S. in Economics from Boston University.

Warren Merlino is the Executive Vice President and Managing Director Logistic Services of PROMOTECH. At PROMOTECH, Warren oversees a full suite of non- personal promotion services for the life sciences industry to include fulfillment, distribution, warehousing, direct mail, database management, tele-services, e-services, print center and direct mail services. In addition, Mr. Merlino serves on the inVentiv Selling Solutions Senior Management Team. With over 21 years of pharmaceutical sales and marketing experience at companies such as Bristol-Myers Squibb and Ciba-Geigy Pharmaceuticals (Novartis), Warren brings a strong skill set in strategic and tactical planning, logistics, marketing, sales, managed care, leadership training and development, and negotiations to PROMOTECH. During the course of his career, Mr. Merlino has had the opportunity to work closely with executives at every level within the health care arena. In his tenure with PROMOTECH, he has led the company through five major company expansions, including the latest, a new 100,000 sq ft. literature distribution center. These changes have enhanced the capabilities available to PROMOTECH clients and positioned this inVentiv division for continued revenue growth. Mr. Merlino earned a B.S. degree in Political Science from Eckerd College in St. Petersburg, Florida as well as an M.B.A. from Emory University in Atlanta, Georgia.

Bryan Horveath is the Senior Vice President and Managing Director for the Ventiv Professional Development Group. Mr. Horveath leads a team of training professionals that design, develop and deliver quality training and development services. Prior to his promotion, Mr. Horveath ran Client Training and Development, where he was responsible for overseeing the management and representative training function for several inVentiv contracts. Mr. Horveath brings more than 14 years of experience in the pharmaceutical industry in the areas of training and development, performance improvement, business development, sales management and marketing on both the client and vendor sides of the business. His diverse sales, marketing and training experience covers a wide range of therapeutic classes, including cardiology, CNS, endocrinology, gastroenterology, pain management and women's health. Mr. Horveath received his B.S. degree in Microbiology from the Pennsylvania State University, and he will be recognized in the 2006-2007 edition of the National Register's Who's Who in Executives and Professionals. He is also a member of the American Society for Training & Development, International Society for Performance Improvement and the Society of Pharmaceutical & Biotech Trainers.

"Steve Gornto is the COO of Sales Operations and Compliance Support for PRS Franklin and Total Data Solutions. He is responsible for the coordination and growth of the whole-system sample management offering, including sampling activities. In addition, he oversees data management, analysis and reporting and sales force effectiveness services supporting inVentiv's biotech and pharmaceutical clients, as well as for business development of the TDS portfolio. Mr. Gornto brings more than 15 years of sales operations, training, and field management experience to inVentiv Health. His leadership skills have enabled him to hold several management positions within Solvay Pharmaceuticals, Noven Pharmaceuticals, and inVentiv Health, including Manager, Sales Operations, Regional Sales Manager and National Sales Director. Mr. Gornto has a B.A. degree in Mathematics and Statistics from the University of West Florida and performed graduate work at Mercer University in Atlanta, Georgia. "

"Tricia Glover is the Chief Compliance Officer for inVentiv Health, and also chairs the Corporate Compliance Committee, which is comprised of members from the inVentiv Commercial Services executive and senior leadership teams. In this role, Ms. Glover is charged with identifying ways in which inVentiv Health can offer efficient processes and programs that comply to PDMA and OIG guidelines both internally and externally. She is committed to providing comprehensive, solution-oriented services and results to both internal and external customers in accordance with the highest ethical principals and all applicable laws and regulations. Ms. Glover brings over 22 years industry experience to inVentiv Health from prior sales, marketing and compliance positions from Teva Neuroscience, Pharmacia/Pfizer and Sanofi-Aventis. Ms. Glover received her B.S. in Business Management from Baker University in Baldwin City, Kansas. "

"A.Clayton Perfall has been a director of the Company since inVentiv’s separation from Snyder Communications, Inc. in September 1999. He currently serves as the Chief Executive Officer of Archway Marketing Services, Inc., a provider of outsourced marketing operations management services. From October 2001 through October 2008, Mr. Perfall served as Chief Executive Officer of AHL Services, Inc. Mr. Perfall also served as President and Chief Executive Officer of Union Street Acquisition Corp from July 2006 through September 2008. From September 1996 through September 2000 Mr. Perfall served as Chief Financial Officer of Snyder Communications, Inc. Prior to joining Snyder Communications, Mr. Perfall was a partner within Arthur Andersen LLP. "

Dr. Saxton, 64, has been a director of the Company since December 2006. Dr. Saxton brings over 40 years of experience in pharmaceutical drug development to inVentiv, initially as a clinical investigator and later through more than 25 years with Pfizer Inc. until his retirement in 2001. During his time with Pfizer, Dr. Saxton worked in a variety of positions in both Europe and the USA in the R&D and International commercial divisions.

Mark Jennings is Managing Partner and co-founder of Generation Partners. Mr. Jennings is responsible for the overall strategic direction, capital commitments and management of the firm. Prior to founding Generation, Mr. Jennings spent eight years at Centre Partners, a private investment firm affiliated with Lazard Freres & Co., where he was elected Partner in 1991 at the age of 29. Mr. Jennings began his career at Goldman Sachs & Co. where he advised companies in the areas of financial strategy, public offerings, mergers & acquisitions and leveraged buyouts. Through Generation and predecessor firms, he has invested in more than 50 companies over the past 19 years and has served on the Board of Directors of 22 companies including: Sterling Infosystems - a leading employment information company, Virtual Radiologic Corporation - the largest distributed teleradiology company, Agility Recovery Solutions - a leading disaster recovery company, The Platform for Media - a provider of digital content software solutions, Medvance Institute - an education firm focused on healthcare occupations, Six Flags (NYSE:SIX), Scientific Games (NASDAQ: SGMS) - world leader in the lottery industry, Snyder Communications (NYSE:SNC) - a global direct marketing and advertising company, Muzak - the nation's leading background music provider, inVentiv Health (NASDAQ:VTIV) - a leading provider of sales, marketing and data services to the pharmaceutical and life sciences industries. Mr. Jennings also serves as the Chairman of the Board of Trustees of Post University, a 115 year-old regionally-accredited University and is on the Board of Directors of The Spiritual Cinema Circle, a multi-faith organization dedicated to spiritually-themed films that inspire, heal and transform. He is also involved with the Starlight-Starbright Children's Foundation and Business Executives for National Security. Mr. Jennings earned his MBA from the Harvard Graduate School of Business in 1986 and earned a Bachelor of Science in Mechanical Engineering with Highest Honors from the The University of Texas at Austin in 1984, where he graduated second in his class and received the University's Rhodes Scholarship nomination.